Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dotarem vs Gadovist in Peripheral Arterial Disease
NCT01026389Phase 4Completed
- Sponsor
- Guerbet
- Start
- Oct 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gadoterate meglumine in Peripheral Arterial Disease (PAD), sponsored by Guerbet. Started Oct 2009; status: completed.
02
Drugs
gadoterate meglumine
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT01026389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01026389.